BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8324656)

  • 1. Clinical applications of positron-emission tomography in cancer.
    Gupta NC; Frick MP
    CA Cancer J Clin; 1993; 43(4):235-54. PubMed ID: 8324656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitating tumor glucose metabolism with FDG and PET.
    Hawkins RA; Choi Y; Huang SC; Messa C; Hoh CK; Phelps ME
    J Nucl Med; 1992 Mar; 33(3):339-44. PubMed ID: 1740699
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
    Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
    Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
    Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.
    Minn H; Paul R
    Eur J Nucl Med; 1992; 19(11):921-4. PubMed ID: 1425778
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
    Block MI; Patterson GA; Sundaresan RS; Bailey MS; Flanagan FL; Dehdashti F; Siegel BA; Cooper JD
    Ann Thorac Surg; 1997 Sep; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in oncology. General acceptance of its role is overdue.
    Lamki LM
    Cancer; 1996 Nov; 78(10):2039-42. PubMed ID: 8918394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Potential use of positron-emission tomography in clinical oncology].
    Fukuda H; Matsuzawa T; Tateno Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of 18F-FDG positron emission tomography in surgical evaluation].
    Franzius C; Sciuk J; Schober O
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():261-9. PubMed ID: 9931622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography: clinical applications in oncology. Part 1.
    Kumar R; Nadig MR; Chauhan A
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer diagnosis with positron emission tomography (PET)].
    Kubota K
    Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
    Mankoff DA; Muzi M; Krohn KA
    Mol Imaging Biol; 2003; 5(5):281-5. PubMed ID: 14630508
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
    Scott WJ; Gobar LS; Hauser LG; Sunderland JJ; Dewan NA; Sugimoto JT
    Chest; 1995 Apr; 107(4):1174-6. PubMed ID: 7705136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography imaging in evaluation of cancer patients.
    Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
    Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
    Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
    J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.